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1. Introduction 
An intensive international research effort is currently underway to develop new classes of 
compounds that exhibit novel mechanisms of antibacterial activity (Bush, 2004) (Klevens et 
al., 2007) due to the dramatic and continued evolution of drug resistant strains of bacteria 
(Hartl, 2000) (Shlaes, Projan, & Edwards, 2004) (Y. Huang, Huang, & Chen, 2010) (Godballe, 
Nilsson, Petersen, & Jenssen, 2011) (J. Song, 2008) (Findlay, Zhanel, & Schweizer, 2010).  
Both natural and synthetic antimicrobial peptides (AMPs) because of their novel 
mechanisms of antibiotic activity, coupled with the inherent difficulty for bacteria to 
develop resistance to them (Hartl, 2000) (Shlaes et al., 2004) (Y. Huang et al., 2010) (Godballe 
et al., 2011) (J. Song, 2008) (Findlay et al., 2010)  exhibit a very high potential as new 
therapeutic agents.  Several AMPs are currently in development as topical antibiotics 
(Zhang & Falla, 2009).  
AMPs have evolved as a host defense mechanism against invading micro-organisms in most 
organisms (Hartl, 2000) (Shlaes et al., 2004) (Y. Huang et al., 2010) (Godballe et al., 2011) (J. 
Song, 2008) (Findlay et al., 2010) . In addition to antibacterial properties AMPs are believed 
to be key players in innate immunity (Devine & Hancock, 2002; Y. M. Song et al., 2005). 
AMPs are normally highly positively charged (+3 to +9) small peptides consisting of 5-50 
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amino acid residues (Hancock, 1998). These peptides are amphipathic molecules with well-
defined hydrophobic and hydrophilic regions (Toke, 2005; Zasloff, 2002). As of January 
2009, more than 1330 (Wang, Li, & Wang, 2009) natural and synthetic antimicrobial peptides 
have been characterized. These peptides have exhibited, a diversity of biological activity 
(Khandelia, 2008).  
The inherent selectivity of AMP’s for prokaryotic vs eukaryotic cells is believed to be 
derived from the difference in the chemical compositions of their respective membranes 
(Dennison, Wallace, Harris, & Phoenix, 2005). Hancock and co-workers (Powers & Hancock, 
2003) have extended this hypothesis to propose that the differences in membrane 
composition between different strains of bacteria are responsible for the diversity in the 
potency and selectivity exhibited by a particular AMP against different strains of bacteria. 
Bacterial cells contain a high percentage of negatively charged phospholipids while 
mammalian cells contain a much higher concentration of zwitterionic phospholipids (Papo 
& Shai, 2003) (Zhang & Falla, 2009) (Findlay et al., 2010) (Godballe et al., 2011) (Y. Huang et 
al., 2010) (Yeaman & Yount, 2003) (Leontiadou, Mark, & Marrink, 2006) (Y. Huang et al., 
2010) (Hancock & Lehrer, 1998). Other differences also exist including membrane 
composition (sterols, lipopolysaccharide, peptidoglycan etc) (Yeaman & Yount, 2003), 
structure, and transmembrane potential and polarizability. These differences are in part 
responsible for the observed selectivity of some AMPs for bacterial vs. mammalian 
cells.(Hancock & Lehrer, 1998; Yeaman & Yount, 2003) Melo and co-workers have 
characterized the physical properties of bacterial membranes that are conducive for AMP 
interactions (Melo, Ferre, & Castanho, 2009).  
The membranes surrounding different types of bacteria are also different. The lipid bilayer 
of Gram positive bacteria is covered by a porous layer of peptidoglycan, while the structure 
of Gram negative bacteria is more complex with two lipid membranes containing 
lipopolysaccharides and porins (Dennison et al., 2005; Giangaspero, Sandri, & Tossi, 2001). 
There is a developing preponderance of evidence in the literature supporting the concept 
that the selectivity and potency of a specific AMP is determined in a large measure by the 
chemical composition of the target membrane.(Powers & Hancock, 2003; Yeaman & Yount, 
2003) 
In our laboratory we have focused on developing antimicrobial peptides that contain 
unnatural amino acids to control the conformational and physicochemical properties (Hicks, 
Bhonsle, Venugopal, Koser, & Magill, 2007) of the resulting peptide.  Our original skeletal 
design of an unnatural AMP incorporated placement of three L-Tic-L-Oic dipeptide units 
into the polypeptide backbone to induce an ordered structure onto the peptide (Hicks et al., 
2007).  The use of the conformationally restrained amino acids (Tic an Oic) reduces the local 
flexibility of the peptide backbone and thus reduces the total conformational space that may 
be sampled by the peptide during lipid binding. The AMPs developed in our laboratory, the 
Tic-Oic units are connected via an amino acid spacer with defined properties of charge and 
hydrophobicity resulting in peptides with well-defined physiochemical properties while 
maintaining sufficient conformational flexibility to allow the peptide to adopt different 
conformations on interacting with membranes of different chemical composition (Hicks et 
al., 2007; Russell et al., 2010; Venugopal et al., 2010).  The basic skeleton of the AMPs under 
investigation is given in Fig. 1.  The amino acid sequences for the AMPs used in this 
investigation are given in Table 1. 
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Fig. 1. The basic skeleton of the new analogs containing six Tic-Oic dipeptide units and the 
five SPACER residues. 
In this report the in vitro antibacterial activity of a new series of AMPs incorporating six Tic-
Oic dipeptide units as well as four additional Spacers, A, B, C and D on either side of the 
intervening hydrophobic and charged residues. These spacers define the overall 
conformational flexibility of the peptide backbone.  A fifth Spacer, E, which defines the 
distance between the polypeptide backbone and the positively charged side chain amine 
group. Spacer E is involved in determining the overall surface charge density of the peptide 
as well as defining the distance between the membrane surface and the polypeptide 
backbone (Hicks et al., 2007). By varying the number of -CH2- groups in Spacer E from 1 to 4 
in the side chain of the basic residues, the distance between the positive charge and the 
peptide backbone will decrease resulting in a) less side chain flexibility during binding –this 
flexibility is more important in the binding with zwitterionic lipids than with anionic lipids; 
and b) the positive charge density will reside closer to the peptide backbone. The additional 
Tic-Oic dipeptide units and spacers were incorporated in hopes of improving the organism 
selectivity of these AMPs.  
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Compound Number/ Amino Acid Sequence 
 
22 H2N-KL-Tic-Oic-K-Tic-Oic-F-Tic-Oic-K-Tic-Oic-F-Tic-Oic-K-Tic-Oic-KR-CONH2 
70 H2N-KL-Tic-Oic-K-Tic-Oic-F-Tic-Oic-K-Tic-Oic-F-Tic-Oic-K-Tic-Oic-KKKK-CONH2 
71 
H2N-Orn-L-Tic-Oic-Orn-Tic-Oic-F-Tic-Oic-Orn-Tic-Oic-F-Tic-Oic-Orn-Tic-Oic-Orn-Orn-Orn-Orn-
CONH2 
72 
H2N-Dpr-L-Tic-Oic-Dpr-Tic-Oic-F-Tic-Oic-Dpr-Tic-Oic-F-Tic-Oic-Dpr-Tic-Oic-Dpr-Dpr-Dpr-
Dpr-CONH2 
73 
H2N-Dab-L-Tic-Oic-Dab-Tic-Oic-F-Tic-Oic-Dab-Tic-Oic-F-Tic-Oic-Dab-Tic-Oic-Dab-Dab-Dab-
Dab-CONH2 
74 H2N-KL-Tic-Oic-GK-Tic-Oic-F-Tic-Oic-GK-Tic-Oic-F-Tic-Oic-GK-Tic-Oic-KKKK-CONH2 
75 H2N-KL-Tic-Oic-K-Tic-Oic-GF-Tic-Oic-K-Tic-Oic-GF-Tic-Oic-K-Tic-Oic-KKKK-CONH2 
76 H2N-KL-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-Oic-KKKK-CONH2 
77 H2N-KL-Tic-Oic-K-Tic-Oic-FG-Tic-Oic-K-Tic-Oic-FG-Tic-Oic-K-Tic-Oic-KKKK-CONH2 
78 H2N-KL-Tic-Oic-KG-Tic-Oic-F-Tic-Oic-KG-Tic-Oic-F-Tic-Oic-KG-Tic-Oic-KKKK-CONH2 
79 H2N-KL-Tic-Oic-KG-Tic-Oic-FG-Tic-Oic-KG-Tic-Oic-FG-Tic-Oic-KG-Tic-Oic-KKKK-CONH2 
Table 1. Amino acid sequences of the compounds understudy 
2. Biological activity 
Antimicrobial peptides (AMP) have evolved in almost every class of living organism as a 
defense mechanism against invading micro-organisms (Yeaman & Yount, 2003) (Dennison 
et al., 2005). The exact mechanism of lipid-induced cytotoxicity of these peptides is currently 
debated in the literature (Powers & Hancock, 2003) with AMPs divided into two 
mechanistic classes, membrane-disruptors and non-membrane-disruptors (Powers & 
Hancock, 2003) (Brogden, 2005). However, there is a general agreement that the first target 
for either membrane-disruptor or non-membrane-disruptor AMPs is the negatively charged 
membranes of bacterial cells (Powers & Hancock, 2003). There are several different 
structural classes of membrane-disruptor AMPs but, for the purpose of this investigation we 
focused on linear amphipathic helical peptides. In many cases these peptides exhibit 
characteristics of a random coil conformation in aqueous or in organic solvents, however on 
binding to micelles or membranes they adopt an ordered amphipathic secondary structure 
(Hicks et al., 2003). This structural class of membrane-disruptors can be divided into two 
sub-classifications based on biological activity: 1) cell selective and 2) non-selective (Y. M. 
Song et al., 2005).  As the name implies cell selective AMPs exhibit potent activity against 
bacterial cells while remaining inactive against mammalian cells, non-selective AMPs 
exhibit activity against bacterial as well as mammalian cells. We have previously reported 
the synthesis and biological evaluation of a series of potent (low µM to nm in vitro activity, 
and low acute toxicity 125 mg/kg in mice) bacteria selective membrane disruptors based on 
the incorporation of three Tic-Oic dipeptide units (Hicks et al., 2007) (Venugopal et al., 2010) 
(Bhonsle, Venugopal, Huddler, Magill, & Hicks, 2007). The in vitro antibacterial activity 
exhibited by the analogs containing six dipeptide units against seven strains of bacteria is 
given in Table 2.  The in vitro antibacterial activity will be discussed as a function of the 
Spacers. The activity of Spacers A and C will be discussed together as will Spacers B and D. 
Spacer E will be discussed separately.  
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Bacteria 
Strain 
Compound  
Number        
 22 70 71 72 73 74 75 76 77 78 79 
Acinetobacter 
baumanii 
ATCC 19606 40.5 9.30 9.77 186 162 4.50 146.00 139 146 144 139 
Acinetobacter 
baumanii 
WRAIR 162 150 156 186 162 144 146.00 139 146 144 139 
Staphylococcus 
aureus ATCC 
33591(MRSA) 162 150 156 186 162 17.90 146.00 139 146 144 139 
Brucella 
melitensis 
16M  162 150 156 186 162 144 73 139 146 144 139 
Bacillus 
anthracis 
AMES  40.5 150 156 186 162 8.97 0.50 139 146 2.20 139 
Francisella 
tularensis 
SCHUS4 81 150 156 186 162 144 146.00 139 146 144 139 
Burkholderia 
mallei  162 150 156 84 81 144 146 139 146 144 139 
Table 2. In Vitro MIC values (µM) for the compounds understudy against drug resistant 
strains and Gram Negative Select Agents. 
2.1 Spacers A and C 
In this series of analogs, Spacer A is the residue preceding each internal Lys residues (N-
terminal side of the Lys) and Spacer C is the residue preceding each internal Phe residue (N-
terminal side of the Phe) as listed in Table 3.  
Compound 22 exhibited good in vitro activity against Acinetobacter baumanii ATCC 19606, 
and Bacillus anthracis AMES and moderate activity against Francisella tularensis SCHUS4 
and poor activity against the other bacteria strains. Replacement of the Lys-Arg residues at 
the C-terminus with four Lys residues in compound 74 changes in vitro activity 
dramatically.  
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Compound number  Spacer A  Spacer C 
  22   Gly   none 
  70   none   none 
  74   Gly   none 
  75   none   Gly 
  76   Gly   Gly  
Table 3. Spacers A and C 
The activity against Acinetobacter baumanii ATCC 19606 and Staphylococcus aureus ATCC 
33591(MRSA) are increased by a factor of 9, and the activity against Bacillus anthracis 
AMES, is increased by a factor of 5, compared to compound 22. Deleting Spacer A (Gly 
residue) of compound 74 and introducing Spacer C (Gly residue) in Compound 75 again 
dramatically changes the activity compared to both compounds 22 and 74.  The activity 
against Acinetobacter baumanii ATCC 19606 is now very poor. However compound 75 
exhibited the highest activity against Bacillus anthracis AMES (80 fold increase over 
compound 74) and Brucella melitensis 16M. Activity against the other bacteria strains was 
very poor. Incorporating both Spacers B and C (both Gly residues) in compound 76 reduced 
the activity to a level that this compound is no longer therapeutically useful. Removing both 
Spacers in compound 70 resulted in a compound selective for Acinetobacter baumanii 
ATCC 19606 and inactive against the remaining bacteria strains. This data indicates that 
combined use of Spacer A and C coupled with increasing the density of the positive charge 
at the C-terminus of the peptide produces organism selectivity.  
2.2 Spacers B and D 
In this series of analogs Spacers B is the residue following each internal Lys residues (C-
terminal side of the Lys) and Spacer D is the residue following each internal Phe residues 
(C-terminal side of the Phe) as listed in Table 4.  
 
Compound Number  Spacer B  Spacer D 
  77   none   Gly 
  78   Gly   none 
  79   Gly   Gly  
Table 4. Spacers D and E 
Incorporation of Spacers D (Gly residues in both cases) in compounds 77 and 79 reduced to 
the activity of these two compounds against all seven strains of bacteria to poor making 
these compounds no longer therapeutically useful. Incorporation of Spacer B (Gly residue) 
only in compound 78 exhibited selective and very good activity against Bacillus anthracis 
AMES. 
2.3 Spacer E 
In this series of analogs, Spacer E replaces the charged Lys residues with charged residues 
with progressively shorter side chains as shown in Table 5. Replacement of the Lys residues 
with Orn residues (one less carbon atom in the side chain) in compound 71 dramatically  
reduces the activity against Staphylococcus aureus ATCC 33591(MRSA) and Bacillus 
The Design of Bacteria Strain  
Selective Antimicrobial Peptides Based on the Incorporation of Unnatural Amino Acids 281 
anthracis AMES, while maintaining the activity against Acinetobacter baumanii ATCC 
19606 as compared to compound 74.  
 
 Compound Number  Spacer E 
71   Orn 
   72   Dpr  
   73   Dab 
  74   Lys  
Table 5. Spacer E 
Replacement of the Lys residues with either Dpr residues (three carbon less) or Dab (two 
carbons less) residues in compounds 72 and 73 respectively dramatically reduces the activity 
against all of the bacteria strains except Burkholderia mallei. Clearly, the length of the side 
chain of Spacer E, and the resulting charge density, plays a major role in determining 
organism potency and selectivity against these seven strains of bacteria. 
3. Characterization of peptide lipid interactions 
The observed differences in bacteria strain selectivity for these compounds are believed to 
be derived directly from the conformational and physicochemical properties presented by 
these AMPs to the surface of the bacteria membrane. Circular Dichroism (CD), isothermal 
calorimetry (ITC) and calcein fluorescence leakage experiments were conducted to provide 
insight into the mechanisms of binding of a series of antimicrobial peptides to simple 
membrane models for bacterial and mammalian cells. LUVs and SUVs consisting of 1-
Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC) were selected as a simple model 
for the zwitterionic membranes of mammalian cells and membrane models consisting of 
(4:1) 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC) / 1-Palmitoyl-2-Oleoyl-sn-
Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium Salt)) (POPG) were selected as a simple model 
for the anionic membranes of bacteria cells (Bringezu et al., 2007) Hicks, 2007 #19}.   
3.1 Calcein leakage studies 
It is well documented that AMPs containing three Tic-Oic dipeptide units exhibited potent 
and selective antibacterial activity (Hicks et al., 2007; Venugopal et al., 2010) and these 
AMPs were designed to be members of the general class of AMPs known as membrane 
disruptors (Shlaes et al., 2004) (Kamysz, 2005) (Zhang, Harris, & Falla, 2005) (Toke, 2005) 
(Godballe et al., 2011) (Ryge, Frimodt-Moller, & Hansen, 2008). Calcein leakage studies 
clearly indicated that the analogs containing three Tic-Oic dipeptides units are in fact 
membrane disruptors (Russell et al., 2010).  The first step in this investigation was to confirm 
that the analogs containing six Tic-Oic dipeptide units are also membrane disruptors. 
Peptide induced calcein leakage from LUVs monitored through fluorescence, is a well 
documented technique for probing AMP activity to confirm membrane disruption 
(Andrushchenko, Aarabi, Nquyen, Prenner, & Vogel, 2008) (Medina, Chapman, Bolender, & 
Plesniak, 2002). Peptides at a concentration of 4μM were introduced to solutions of either 
POPC or 4:1 POPC/POPG LUVs containing encapsulated 70 mM calcein (Figure 2) and the 
resulting induced fluorescence due to leakage of calcein was monitored over a 90 minute 
time period. 
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Fig. 2. Induced leakage of calcein from TOP) POPC LUVs and BOTTOM) 4:1 POPC/POPG. 
The induced calcein leakage data indicates that all AMPs in this investigation interact in a 
very similar fashion with both zwitterionic (POPC) and anionic (4:1 POPC/POPG) LUVs. 
This data also strongly suggests that the mechanism of action of these AMP involves some 
type of membrane disruption. However, this data doesn’t explain the observed organism 
selectivity. The observed induced calcein induce leakage behavior of the analogs containing 
six Tic-Oic dipeptide units is very different from that observed for the corresponding three 
Tic-Oic dipeptide containing analogs. The analog containing three Tic-Oic dipeptide units 
corresponding to compound 74 has the amino acid sequence: Ac-GF-Tic-Oic-GK-Tic-Oic-
GF-Tic-Oic-GK-Tic-KKKK-CONH2 (compound 23) (Russell et al., 2010). For compound 23 
different concentrations of peptide (4 – 20 μM) were introduced to solutions of either POPC 
or 4:1 POPC/POPG LUVs and their induced fluorescence, due to leakage of calcein was 
monitored over a 90 minute time period. It can be seen in Fig. 3, compound 23 interacts with 
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POPC LUVs, inducing calcein leakage, in a non linear concentration dependent manner 
(Russell et al., 2010). However, compound 23 induces calcein leakage from 4:1 POPC/POPG 
LUVs in a concentration dependent manner. This data indicates the analogs containing three 
Tic-Oic dipeptide units interact with zwitterionic POPC LUV and anionic 4:1 POPC/POPG 
LUVs via different mechanisms (Russell et al., 2010). This data also indicates that the 
incorporation of three additional Tic-Oic dipeptide units, and thus increasing the overall 
length of the peptide, changes the mechanism of binding with both types of LUVs. 
     
Fig. 3. The calcein leakage induced by compound 23 as a function of peptide concentration 
from LEFT) POPC LUVs and RIGHT) 4:1 POPC/POPG LUVs 
The corresponding experiment using compound 74 were conducted. Compound 74 at 
various concentrations (4 – 20 μM) was introduced to solutions of either POPC or 4:1 
POPC/POPG LUVs and their induced fluorescence, due to leakage of calcein was 
monitored over a 90 minute time period. It can be seen in Fig. 4, that compound 74 interacts 
with POPC LUVs, and 4:1 POPC/POPG LUVs in a totally concentration independent 
manner. In fact almost 100% calcien leakage was observed at all concentrations. This 
suggests that the analogs containing six Tic-Oic dipeptide units bind to the surface of the 
LUV and cause the LUV to lysis or break down in some fashion. After causing this 
disruption of the surface of the LUVs these peptides most likely then separate from the 
“disrupted” LUV and bind to another LUV and repeat the process. 
3.2 Circular dichroism studies 
Circular dichroism (CD) spectroscopy is very sensitive and its use to monitor 
conformational changes in peptides and proteins is well documented (Glattli, Daura, 
Seebach, & van Gunsteren, 2002), (Ladokhin, Selsted, & White, 1999) (Ladokhin, Vidal, & 
White, 2010). Traditionally, SUVs have been employed almost exclusively to investigate the 
binding of peptides and proteins with lipids in CD studies in order to minimize the 
contribution of light scattering on the spectra (Ladokhin et al., 2010) (C. H. Huang, 1969).  
In the analysis of CD data, it must be noted that the spectrum of a peptide represents the  
linear combination of a number of different conformers (Glattli et al., 2002)-(Berova, Nakanishi, 
& Woody, 2000). This is particularly true when liposomes are used as there are several 
different peptide-liposome interactions possible depending on the lipid to peptide ratio.  
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Fig. 4. The calcein leakage induced by compound 74 as a function of peptide concentration 
from LEFT) POPC LUVs and RIGHT) 4:1 POPC/POPG LUVs 
Changes in the intensity or shape of the CD spectrum of a peptide in the presence of a 
liposome indicate that the peptide is adopting different conformations on interacting with 
that particular liposome as compared to another environment such as a buffer. (Berova et 
al., 2000; Glattli et al., 2002).  Due to the high percentage of unnatural amino acids 
incorporated into the peptide under investigation here, no quantitative estimation of 
secondary structural features are possible. Therefore, analysis of CD spectra will be limited, 
at best, to qualitative comparisons highlighting differences in the spectra of these 
compounds with references to possible secondary structural features. 
3.2.1 CD spectra in buffer 
The CD spectra of 100 µM solutions of compounds 22, 70, 71, 72, 73, 74, 75, 76, 77, 78 and 79 
in 40 mM phosphate buffer, pH = 6.8 are given in Fig. 5. As can be seen in Fig. 5, these 
peptide adopt a variety of different conformations varying from random coil to possible  
β-sheet like. However, overall these peptides are unordered in buffer only. 
 
Fig. 5. Far-UV Circular Dichroism spectra of 100 µM solutions of compounds 22, 70, 71, 72, 
73, 74, 75, 76, 77, 78 and 79 in 40 mM phosphate buffer, pH = 6.8. 
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3.2.2 CD spectra in the presence of POPC SUVs 
The CD spectra of compounds 70, 71, 72, 73, 74, 75, 76, 77, 78 and 79 in the presence of 1.75 
mM POPC SUVs are shown in Fig. 6.  This figure illustrates the diversity of conformations 
adopted by these compounds on binding to POPC SUVs. The CD spectra of these 
compounds in the presence of POPC SUVs are different in most cases from the 
corresponding spectra in buffer.  This indicates that these compounds are interacting with 
the POPC SUVs via some mechanism. This is consistent with the very strong interactions 
observed with POPC LUVs in the induced calcein leakage studies. From this figure it is 
difficult to characterize the conformational difference associated with the variations in the 
five Spacers. To accomplish analysis, these CD spectra will be divided into smaller sub sets 
of spectra. 
The first sub set of CD spectra to be discussed will be those of compounds 70, 74, 75, and 76 
which contain Spacers A or C, or both. The CD spectra of these four compounds, given in 
Fig. 7, are different indicating that these compounds adopt different conformations on 
binding to POPC SUVs. This observation is critical in explaining possible organism 
selectivity. Since this POPC SUVs are a model for mammalian cells, this data suggests that 
these compounds would adopt different conformations on binding to red blood cells. From 
a therapeutic perspective this information may allow for the development of analogs with 
reduced toxicity. The CD spectrum of compound 75 exhibits a maxima at approximately 195 
nm and double minima at approximately 220 and 205 nm which would suggest the presence 
of α-helical conformers (Ladokhin et al., 1999) (Fuchs et al., 2006).  While the CD spectra of 
compounds 74 and 76 exhibit double minima at approximately 220 and 205 nm without the 
maxima at 195 nm suggesting these compound adopt a mixture of β-turn and β-sheet like 
conformers on binding to POPC SUVs (Ladokhin et al., 1999) (Fuchs et al., 2006). The CD 
spectrum of compound 70 exhibits a maxima at approximately 195 nm, however no negative 
minima is observed. It is very difficult to qualitatively characterize the possible secondary 
structures adopted by compound 70.   
 
Fig. 6. Far-UV Circular Dichroism spectra of 100 µM solutions of compounds 70, 71, 72, 73, 
74, 75, 76, 77, 78 and 79 in the presence of 1.75 mM POPC SUV in 40 mM phosphate buffer, 
pH = 6.8. 
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Fig. 7. Far-UV Circular Dichroism spectra of 100 µM solutions of compounds 70, 74, 75 and 
76 in the presence of 1.75 mM POPC SUV in 40 mM phosphate buffer, pH = 6.8 
The next sub set of CD spectra to be discussed in the presence of 1.75 mM POPC SUVs are of 
compounds 77, 78 and 79 (Fig. 8) which contain Spacers B and D.  The CD spectrum of 
compound 77 is similar in shape and intensity to the CD spectrum of compound 70, and 
therefore it is very difficult to qualitatively characterize the possible secondary structures 
adopted by compound 77. While compounds 78 and 79 exhibited similar CD spectra to each 
other, both with minim at approximately 202 to 205 nm, it is very difficult to qualitatively 
characterize the possible secondary structures adopted by compounds 78 and 79, however, 
this suggests these compound adopt a mixture of β-turn and β-sheet like conformers on 
binding to POPC SUVs (Ladokhin et al., 1999) (Fuchs et al., 2006) . What is clear from these 
three CD spectra is Spacer D (compound 77) doesn’t play a major role in stabilizing a 
particular secondary structure on binding to POPC SUVs. Spacer B (contained in 
compounds 78 and 79) seems to play a more significant role in stabilizing a β-turn/sheet 
conformation on binding to POPC SUVs.  
 
Fig. 8. Far-UV Circular Dichroism spectra of 100 µM solutions of compounds 77, 78 and 79 
in the presence of 1.75 mM POPC SUV in 40 mM phosphate buffer, pH = 6.8. 
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The last sub set of CD spectra to be discussed in the presence of 1.75 mM POPC SUVs are 
those of compounds 71, 72, 73, and 74 (Fig. 9) which contain Spacer E. Compounds 71, and 
74 exhibit double minima at approximately 220 and 205 nm without the maxima at 195 nm 
suggesting these compound adopt a mixture of β-turn and β-sheet like conformers on 
binding to POPC SUVs (Ladokhin et al., 1999) (Fuchs et al., 2006).  While the CD spectrum of 
compound 72 exhibits characteristics of a random coil conformation. The CD spectrum of 
compound 73 exhibited a maxima at approximately 195 nm and a double minima at 
approximately 220 and 205 nm which would suggest the presence of α-helical conformers 
(Ladokhin et al., 1999) (Fuchs et al., 2006).  This data clearly indicates that the length of 
Spacer E and the resulting location of the positive charge density relative to the peptide’s 
backbone plays a major role in determining the conformations adopted by these peptides on 
binding to POPC SUVs. 
 
Fig. 9. Far-UV Circular Dichroism spectra of 100 µM solutions of compounds 71, 72, 73, and 
74 in the presence of 1.75 mM POPC SUV in 40 mM phosphate buffer, pH = 6.8. 
3.2.3 CD spectra in the presence of 4:1 POPC/POPG SUVs 
The CD spectra of compounds 22, 70, 71, 72, 73, 74, 75, 76, 77, 78 and 79 in the presence of 
1.75 mM 4:1 POPC/POPG SUVs are shown in Fig. 10.  This figure illustrates the diversity of 
conformations adopted by these compounds binding to 4:1 POPC/POPG SUVs. The CD 
spectra of these compounds in the presence of 4:1 POPC/POPG SUVs are different in most 
cases from the corresponding spectra in buffer.  This indicates that these compounds are 
interacting with the 4:1 POPC/POPG SUVs. From this figure it is difficult to characterize the 
conformational difference associated with the variations in the five Spacers. To accomplish 
this analysis, these CD spectra will be divided into smaller sub sets of spectra. As will 
become evident from the analysis of the sub sets of spectra, many of these compounds adopt 
different conformation on binding to POPC and 4:1 POPC/POPG SUVs.  
The first sub set of spectra to be discussed will be focused on Spacers A and C, consisting of 
compounds 70, 74, 75, and 76. The CD spectra (Fig. 11) of these four compounds are 
different indicating that these compounds adopt different conformations on binding to 4:1 
POPC/POPG SUVs. The differences in the CD spectra for these compounds binding to 4:1 
 
A Search for Antibacterial Agents 288 
POPC/POPG SUVs is critical in that it helps to explain the observed organism selectivity 
between the different bacteria strains. The CD spectrum of compound 75 exhibits a maxima 
at approximately 195 nm and double minima at approximately 220 and 205 nm which 
would suggest the presence of α-helical conformers just as it did in the presence of POPC 
SUVs (Ladokhin et al., 1999) (Fuchs et al., 2006).   
 
Fig. 10. Far-UV Circular Dichroism spectra of 100 µM solutions of compounds 22, 70, 71, 72, 
73, 74, 75, 76, 77, 78 and 79 in the presence of 1.75 mM 4:1 POPC/POPG SUV in 40 mM 
phosphate buffer, pH = 6.8. 
The CD spectra of compounds 76 exhibited a double minima at approximately 220 and 205 
nm without the maxima at 195 nm suggesting these compound adopt a mixture of β-turn 
and β-sheet like conformers on binding to 4:1 POPC/POPG SUVs just as it did with POPC 
SUVs (Ladokhin et al., 1999) (Fuchs et al., 2006). The CD spectrum of compound 70 exhibits 
a weak maxima at approximately 195 nm and a weak double minima at approximately 220 
and 205 nm is also observed which would suggest the presence of α-helical conformers just 
as it did in the presence of POPC SUVs (Ladokhin et al., 1999) (Fuchs et al., 2006). This CD 
spectrum is different from the one observed in the presence of POPC SUVs.  The CD 
spectrum of compound 74 was very interesting as it exhibits only a single minima at 
approximately 205 nm. Also the overall spectra intensity is less than that observed in the 
presence of POPC SUVs.  
The second set of CD spectra to be discussed are of compounds 77, 78 and 79 (Fig. 12) 
(Spacers B and D) in the presence of 4:1 POPC/POPG SUVs. The CD spectrum of compound 
77, unlike in the presence of POPC SUVs, is very different in shape and intensity from the 
CD spectrum of compound 70. Compound 77 in the presence of 4:1 POPC/POPG SUVs 
exhibits a strong and a weak minima at approximately 207 nm. Again compounds 78 and 79 
exhibited similar CD spectra to each other both with minima at approximately 202 to 205 
nm. These spectra are similar to those observed in the presence of POPC SUVs. These CD 
spectra are different in shape, thus implying a different conformation of binding to the 
SUVs, from the CD spectra of the active analogs, which from a therapeutic respective is a 
critical observation. 
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Fig. 11. Far-UV Circular Dichroism spectra of 100 µM solutions of compounds 22, 70, 74, 75, 
and 76 in the presence of 1.75 mM 4:1 POPC/POPG SUV in 40 mM phosphate buffer, pH = 
6.8. 
 
Fig. 12. Far-UV Circular Dichroism spectra of 100 µM solutions of compounds 77, 78 and 79 
in the presence of 1.75 mM 4:1 POPC/POPG SUV in 40 mM phosphate buffer, pH = 6.8. 
The fact that the CD spectra of the inactive compounds 77, 78 and 79 in the presence of 4:1 
POPC/POPG SUVs are very different from the CD spectra of the active compounds 
supports our hypothesis that the incorporation of multiple Tic-Oic dipeptide units that are 
connected via an amino acid spacer with defined properties of charge and hydrophobicity 
will result in peptides with well-defined physiochemical properties while maintaining 
sufficient conformational flexibility to allow the peptide to adopt different conformations on 
interacting with membranes of different chemical compositions, and thus exhibit organism 
selectivity. 
The last sub set of CD spectra to be discussed in the presence of 1.75 mM 4:1 POPC/POPG 
SUVs are those of compounds 71, 72, 73, and 74 (Fig. 13) which contain Spacer E. The CD 
spectra of compounds 71, and 73 exhibited a maxima at approximately 195 nm and a double 
minima at approximately 220 and 205 nm which would suggest the presence of α-helical 
conformers (Ladokhin et al., 1999) (Fuchs et al., 2006). In the presence of POPC SUVs the CD 
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spectrum of compound 71 exhibit double minima at approximately 220 and 205 nm without 
the maxima at 195 nm suggesting that this compound adopts a mixture of β-turn and β-
sheet like (Ladokhin et al., 1999) (Fuchs et al., 2006).  While the CD spectrum of compound 
72 exhibits a minima at approximately 195 nm. This spectrum was very different from the 
CD spectrum observed in the presence of POPC SUVs. The CD spectrum of compound 74 
exhibited a double minima at approximately 220 and 205 nm which would suggest the 
presence of β−turn or β- sheet conformers (Ladokhin et al., 1999) (Fuchs et al., 2006). Again 
the observed difference in the CD spectra in the presence of 4:1 POPC/POPG SUVs are 
consistent with the observed differences in bacteria strain selectivity and potency. 
 
Fig. 13. Far-UV Circular Dichroism spectra of 100 µM solutions of compounds 71, 72, 73, and 
74 in the presence of 1.75 mM 4:1 POPC/POPG SUV in 40 mM phosphate buffer, pH = 6.8. 
3.3 Isothermal titration calorimetry studies 
The isothermal titration calorimetry (ITC) binding enthalpies for peptides with SUVs, 
generally, are more exothermic than those in the presence of LUVs. Therefore, SUVs are not 
ideal membrane models for thermodynamic measurements. (Beschiaschvili & Seelig, 1992; 
Seelig & Ganz, 1991; Wieprecht, Apostolov, & Seelig, 2000). LUVs formed by extrusion 
methods are equilibrium structures and are more appropriate to use as a membrane model 
in thermodynamic studies (Enoch & Strittmatter, 1979). ITC studies were conducted on the 
most active analogs in hopes of gaining insight into the possible explanations for the 
observed organism selectivity.  
3.3.1 ITC studies of POPC LUVs 
The application of isothermal titration calorimetry (ITC) to the study of peptide-membrane 
interactions is well documented in the literature (Hunter et al., 2005) (Wieprecht, 
Beyermann, & Seelig, 2002) (Meier & Seelig, 2007).  The binding interactions between these 
AMPs and 35 mM POPC LUVs was investigated using ITC. In an ideal case, ITC would 
allow for the complete analysis of the thermodynamic parameters (free energy, enthalpy, 
entropy, binding constants and heat capacity changes) associated with the binding 
interactions between peptides and LUVs (Wieprecht et al., 2002) (Thomas, Surolia, & 
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Surolia, 2001). The interaction of peptides with lipid vesicles are driven by three forces: the 
hydrophobic effect, the coil-helix transition and non-classical hydrophobic effect (Wieprecht, 
Apostolov, Beyermann, & Seelig, 2000) (Wieprecht, Beyermann, & Seelig, 1999). Further, 
Wieprecht and co-workers (Wieprecht, Apostolov, Beyermann, et al., 2000) proposed that 
the binding of a peptide to a LUV is dependent on the global structural physicochemical 
properties including the overall charge, hydrophobicity, and amphipathicity of the AMP.  
As seen in Fig. 14 the titration of 35 mM POPC LUVs into compounds 22, 70, 71, 72, 74, 75, 
resulted in different thermograms, suggesting that the process that contributes to the 
binding interactions vary in magnitude with each peptide.  All six peptides begin their 
thermograms with an endothermic phase (Wieprecht, Apostolov, Beyermann, et al., 2000). 
Previous studies reported in the literature (Abraham, Lewis, Hodges, & McElhaney, 2005) of 
the interaction between peptides and lipids using ITC have noted that an endothermic 
phase can be attributed to a combination of several events. These events may include 
electrostatic interactions between the peptide and the membrane surface, disruption of polar 
head groups accompanied by reorganization of lipids on the surface of the membrane, 
disruption of the solvation spheres on both the peptide and the membrane surfaces, and 
other less understood phenomena (Abraham et al., 2005).  
Compounds 22, 74 and 75 all produced single endothermic phases. With these compounds, 
titration with POPC resulted in the continuous decrease of heat as the experiment 
progressed until only the heat of dilution was observed. This behavior is similar to that 
previously observed for compound 23. While compounds 70, 71 and 72 all produced two 
phased thermograms. These thermograms begin with an endothermic phase of varying 
intensity and then transition into a second exothermic phase of varying intensity. 
This behavior is rare, but not unknown. Jelokhani-Niaraki et. al. reported a similar 
observation for the interaction of aromatic amino acid analogues of gramicidin S with 
phospholipid membranes (Jelokhani-Niaraki, Hodges, Meissner, Hassenstein, & Wheaton, 
2008). Andrushchenko and co-workers reported similar thermograms for the binding of 
the tryptophan-rich cathelicidin antimicrobial peptides tritrpo4 and tritrpo6 with 7:3 
POPE/POPG LUVs (Andrushchenko et al., 2008). This type of two phased thermogram 
was not observed for the titration of the corresponding three Tic-Oic didpeptide 
containing analogs into POPC LUVs, only single phased endothermic thermograms were 
observed. 
Several factors may contribute to the observed enthalpies of binding to LUVs such as 
attractive and repulsive electrostatic interactions, conformational changes of the peptide, 
changes in Van der Waals contacts due to the dehydration of both the peptide and 
membrane surfaces and disruption of polar head groups on the surface of the LUV (Seelig, 
1997) (Andrushchenko et al., 2008) (Seelig, 2004) (Abraham et al., 2005).The endothermic 
heat event occurring at low lipid to peptide ratios has been interpreted as the summation of 
several simultaneous processes. These processes include, but are not limited to, pore 
formation (Wieprecht, Apostolov, Beyermann, et al., 2000), peptide aggregation 
(Andrushchenko et al., 2008), as well as changes in the phase properties of the lipids at 
different points during the titration (Epand, Segrest, & Anantharamaiah, 1990) (Seelig, 2004). 
The exothermic heat event at high lipid-to-peptide ratios has been attributed to the binding 
of the peptide to lipid surfaces (Seelig, 1997).  
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Fig. 14. The ITC thermograms of POPC LUVs titrated into compounds 22, 70, 71, 72, 74, and 
75. 
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3.3.2 ITC studies of 4:1 POPC/POPG LUVs 
Titration of 35 mM 4:1 POPC/POPG LUVs into compounds 22, 70, 71, 74 and 75 all resulted 
in two phased thermograms beginning (Fig. 15) with an endothermic phase of varying 
intensity transitioning into an exothermic phase of varying intensity. This behavior is similar 
to that previously observed for compound 23 (Russell et al., 2010). This behavior is very 
similar to the thermograms observed for the three Tic-Oic dipeptide containing analogs. Not 
only does the magnitude of the endothermic and exothermic components vary, also the 
transition point between the endothermic and exothermic phase vary at different lipid to 
peptide molar ratios. These ratios are given in Table 6. Replacement of the Lys residues in 
compound 74 with Orn residues in compound 71 reduce the lipid to peptide ratio for the 
transition from the endothermic to the exothermic phase from 30 to 12. This reduction in the 
lipid to peptide ratio for the transition from the endothermic to the exothermic phase may 
possibly help explain the reduction in the overall antibacterial activity of compound 71 
compared to compound 74. Also compound 22 exhibits the most intense exothermic phase 
of the five compounds investigated, at a lipid to peptide ratio for the transition from the 
endothermic to the exothermic phase of 18. This observation suggests that a combination of 
factors such as the lipid to peptide ratio for the transition from the endothermic to the 
exothermic phase, and the magnitude of the exothermic and endothermic phase all play 
major roles in defining antibacterial  activity, with no single factor correlating directly with 
the observed antibacterial activity.  
 
 
Compound   Lipid to Peptide Ratio for transition 
22    18 
70    18 
71    12 
74    30 
  75    10    
Table 6. Lipid to Peptide molar ratios for the transition from the endothermic to the 
exothermic phase of the thermogram for the titration of 4:1 POPC/POPG LUVs into the 
following peptides 
As previously stated there is a growing preponderance of evidence in the literature, 
indicating that the selectivity and potency of a specific AMP for bacterial cells is 
determined in a large measure by the chemical composition of the target cell’s membrane 
(Powers & Hancock, 2003; Yeaman & Yount, 2003). Thus we and other researchers have 
postulated that the bacteria cell membrane’s physicochemical surface interactions with the 
physicochemical surface of the AMP defines organism selectivity.(Dennison et al., 2005; 
Giangaspero et al., 2001; Glukhov, Stark, Burrows, & Deber, 2005; Powers & Hancock, 
2003)  In addition, it is our hypothesis that the physicochemical properties of the target 
cell’s membrane interact with the physicochemical properties of the approaching AMP 
defining its selectivity and potency against that particular cell. During this process 
conformational changes are induced onto the AMP that will maximize the attractive 
interactions between the two to facilitate AMP-membrane binding. The observation of 
different thermograms for these compounds on interacting with POPC and 4:1 
POPC/POPG LUVs supports our hypothesis.  
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Fig. 15. ITC thermogram of the titration of 4:1 POPC/POPG into compounds 22, 70, 71, 74, 
75.  
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4. Material and methods 
Sodium dodecyl sulfate (SDS) and Bis-Tris buffer were purchased from Sigma-Aldrich. 
Monobasic and dibasic sodium phosphate, EDTA and NaCl were purchased from Fischer 
Scientific. POPC (1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine), POPG (1-Palmitoyl-2-
Oleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium Salt)) and Dodecylphosphocholine 
(DPC) were purchased from Avanti Polar Lipids. High purity calcein was purchased from 
Invitrogen. All chemicals were used without further purification. 
4.1 Peptide synthesis 
Peptide synthesis was performed either manually using tBOC chemistry or with an 
automated peptide synthesizer using FMOC chemistry (Grant, 2002) as previously reported 
(Hicks et al., 2007) (Venugopal et al., 2010) (Russell et al., 2010). All peptides were purified 
by Reverse Phase HPLC using an Agilent 1100 Series Preparative Instrument and a Vydac 
C18 Reverse Phase Preparative HPLC Column as previously reported (Venugopal et al., 
2010) (Russell et al., 2010). All purified peptides were analyzed again by HPLC and Mass-
Spec. Mass Spectral analyses were carried out using a Finnigan LTQ ESI-MS instrument 
running Xcalibur 1.4SR-1 or a Kratos PC Axima CFR Plus instrument (MALDI) running 
Kompact V2.4.1. ESI-MS showed multiply charged ions and the accurate mass was 
calculated. MALDI analyses were performed in reflectron mode (Venugopal et al., 2010) 
(Russell et al., 2010).  
4.2 Preparation of POPC and 4:1 POPC/POPG SUVs 
The appropriate amount of dried POPC or 4:1 POPC/POPG (mol to mol) lipid was weighed 
out to yield a final lipid concentration of 35 mM. The lipid was dissolved in chloroform and 
vortexed for 3 minutes.  The sample was dried under a stream of nitrogen gas for four hours 
and under high vacuum overnight. The lipid was then hydrated with 2 mL of buffer (40 mM 
sodium phosphate, pH = 6.8) and vortexed extensively. SUVs were prepared by sonification 
of the milky lipid suspension using a titanium tip ultrasonicator (Qsonica Sonicators model 
Q55) for approximately 40 minutes in an ice bath until the solution became transparent. The 
titanium debris was removed by centrifugation at 14,000 rev/min for 10 minutes using an 
Eppendorf table top centrifuge (Wieprecht, Apostolov, & Seelig, 2000). It has been reported 
that the mean diameter for SUVs formed by sonication is approximately 30 nm (C. H. 
Huang, 1969; Ladokhin et al., 2010). Final concentration used for CD was 1.75 mM or as 
otherwise stated in the text.  
4.3 Preparation of POPC and 4:1 POPC/POPG LUVs 
A defined amount of dried POPC or 4:1 POPC/POPG (mol to mol) was weighed, 
suspended in buffer (40 mM sodium phosphate, pH = 6.8) and spun for 30 minutes, 
resulting in a total lipid stock solution concentration of 35 mM. Other concentrations of 
LUVs used are noted in the text and resulted from the dilution of the stock solution. Large 
unilamellar vesicles (LUVs) were prepared by extrusion using a Mini-Extruder (Avanti 
Polar Lipid Inc) (Wei, 2006) (Hunter et al., 2005). The solution was extruded through a 100 
nm pore size polycarbonate membrane 21 times. After extrusion the LUVs were allowed to 
“rest” for at least two hours before use to allow for equilibration to occur. The final lipid 
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concentration was calculated based on the weight of the dried lipid (Wieprecht, Apostolov, 
& Seelig, 2000) (Wieprecht, Apostolov, Beyermann, et al., 2000) (Russell et al., 2010) 
(Wieprecht et al., 2002) (Wieprecht & Seelig, 2002) (Wen, 2007). Kennedy and co-workers 
previously reported the preparation of LUVs using this procedure resulting in a 
homogeneous population of LUVs with >95% of the particles falling into the particle size 
range of 70-100 nm (Kennedy et al., 2002). We have also previously shown by 31P NMR that 
these LUVs are unilamellar (Kennedy et al., 2002). 
4.4 LUVs for calcein release experiments 
A defined amount of dried POPC or 4:1 POPC/POPG LUVs (mol to mol) was weighed and 
suspended in a calcein-containing buffer (70mM calcein, 10mM Bis-Tris, 150mM NaCl, 1mM 
EDTA, pH=7.1, the pH was corrected using 3mM NaOH and the final calcein concentration 
was calculated based on dilution). The resulting solution was vortexed for one minute (5 
times). The calcein-encapsulated LUVs were extruded using the same technique as described 
above. Following extrusion the unencapsulated calcein was removed by gel filtration on a 
Sephadex G50 column (eluent: buffer containing 10 mM Bis-Tris, 150 mM NaCl, 1 mM EDTA, 
pH =7.1) The fraction containing calcein-encapsulated liposomes was collected and retained 
for fluorescence studies (Wieprecht, Apostolov, & Seelig, 2000) (Wieprecht, Apostolov, 
Beyermann, et al., 2000) (Russell et al., 2010) (Wieprecht et al., 2002) (Wieprecht & Seelig, 
2002) (Wen, 2007) (Wieprecht et al., 1996) (Dathe, 1996) (Tamba & Yamazaki, 2005). Prior to 
use each batch of calcein encapsulated LUVs was subjected to a self-quenching efficiency test. 
The self-quenching efficiency (Q) for each lipid suspension was set at a minimum value of 
80% before it could be used in these investigations. The Q value was calculated using the 
following equation: Q = (1 – (F0/FT)) X 100% where F0 and FT are the background 
fluorescence of the lipid suspension and the total fluorescence after the addition of a solution 
of 10% Triton X, respectively (Jing, Hunter, Hagel, & Vogel, 2003) (Benachir & Lafleur, 1995) 
(Tachi T, Epand RF, Epand RM, & K., 2002 ) (Mason, Marquette, & Bechinger, 2007). 
4.5 Circular dichroism studies 
Peptide stock solutions were dissolved in 40mM phosphate buffer (pH = 6.8). Binding studies 
were conducted using SUV preparations consisting of 1.75 mM POPC or 4:1 POPC/POPG in 
40 mM phosphate buffer (pH = 6.8) with peptide concentrations of 100 μM. All CD spectra 
were obtained by acquiring 8 scans on a Jasco J-815 CD Spectrometer using a 0.1 mm 
cylindrical quartz cell (Starna Cells, Atascadero, CA) from 260 to 178 nm at 20 nm/min, with 
a 1 nm bandwidth, a data pitch of 0.2 nm, a response time of 2.0 sec and a sensitivity of 5 
mdeg at room temperature (~25°C). Contributions due SUVs were eliminated by subtracting 
the lipid spectra of the corresponding peptide-free solutions. All analysis of CD spectra was 
conducted after smoothing (with a means-movement function) and conversion to molar 
ellipticity using the JASCO Spectra Analysis program (Russell et al., 2010) (Wei, 2006) 
(Bringezu et al., 2007). CD spectra that exhibited HT values greater than 400 were not used 
due to excessive light scattering and / or absorption.  
4.6 Isothermal titration calorimetry studies 
Data was acquired using a Microcal VP-ITC calorimeter (Microcal, Northampton, MA). All 
experiments were run in 40 mM sodium phosphate buffer, pH = 6.8, at 25ºC. All solutions 
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were degassed for approximately 10 minutes under vacuum before loading the reaction cell 
and syringe. For full titration experiments, 15 μL aliquots of 35 mM lipid solutions in buffer 
were titrated into peptide (100 – 200 μM).  For binding single injection experiments, 15 μL of 
dilute samples of peptide (100-200 μM) were titrated into excess lipid (15-20 mM). A stirring 
speed of 220 rpm and injection duration of 30 sec were chosen to ensure sufficient mixing 
while keeping the baseline noise to a minimum. To ensure complete equilibration between 
injections, a delay of 700 sec between injections was used. The background heat of dilution 
was obtained by titrating LUVs into the reaction cell containing only buffer and was 
subtracted prior to analysis. Data was analyzed with Origin® software (version 7.0). ITC 
data collection was obtained in duplicate in an effort to ensure reproducibility (Wieprecht, 
Apostolov, & Seelig, 2000) (Wieprecht, Apostolov, Beyermann, et al., 2000) (Russell et al., 
2010) (Wei, 2006) (Wieprecht et al., 2002) (Wieprecht & Seelig, 2002) (Wen, 2007).  
4.7 Calcein leakage assays 
Peptide induced calcein leakage studies were conducted using an ISS PC1 photon counting 
spectrofluorometer (ILC Technology) at an excitation wavelength of 494 nm and an emission 
wavelength of 518 nm. An aliquot of peptide (4 – 20 μM) in buffer (10 mM Bis-Tris, 150 mM 
NaCl, 1 mM EDTA, pH = 7.1) was added to the cell containing calcein-encapsulated 
liposomes (36.6 μM lipid concentration). Measurements were taken every minute for the first 
20 minutes of the experiment and every 10 minutes after until no further changes in the 
emission intensity occurred (approximately 90 minutes). To determine the maximum 
fluorescence intensity that corresponded to hundred percent leakage, an aliquot of 10 μL of a 
10% Triton X solution was added to the sample at the end of each experiment. The apparent 
percent leakage was calculated using the following equation: % leakage = [(FI-F0)/FT)] x 100 
%, where F0 and FT are the initial fluorescence before introduction of peptide and after the 
addition of Triton X, respectively (Dathe, 1996; Russell et al., 2010) (Wieprecht, Apostolov, 
Beyermann, et al., 2000) (Tamba & Yamazaki, 2005) (Wieprecht et al., 1996) (Wei, 2006). 
4.8 Preparation of bacteria samples 
A small amount of the organism was streaked onto the appropriate agar plates and the 
plates incubated at either 30° or 37° C (depending on organism to be tested – Plague and 
Anthrax were incubated at 30°, Brucella, Francisella, and Burkholderia were incubated at 
37°C ) overnight.  At the end of the incubation period the organisms were harvested using a 
sterile loop and suspended into a 15 mL centrifuge tube containing 5 mL Mueller Hinton 
Broth + IsoVitaleX (Bekton Dikinson, Inc.) and thoroughly mixed. A standardized 
suspension of 1.0 OD600 was prepared from a suspension using sterile saline as the diluent 
and the absorbance was read against a tube containing saline only as a blank using either a 
spectrophotometer (Spectronix 20, Bausch & Lomb, Inc.) or by a microplate reader 
(Spectramax Plus384, Molecular Devices, Inc.) at a wavelength of 600nm. The suspension 
was adjusted to obtain a volume of 5 mL containing a 1.0 OD solution. One 50 mL 
disposable Erlenmeyer flask containing 20mL of broth with 1 mL of the organism dilution 
was then inoculated for 24-48 hours (dependent on growth characteristics of the organism in 
question) in a shaking incubator rotating at 200 rpm (Standards, 2000) (Standard, 2002) 
(Venugopal et al., 2010) . After 24-48 hours, the suspension was thoroughly mixed, the tubes 
centrifuged at high speed (2,000 x g) for 15 minutes, the supernatant removed, and the 
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pelleted organisms resuspended to yield a total volume of 45 mL. This was repeated for a 
total of 3 washes. After the final wash the pelleted organisms were resuspended in 15 mL of 
broth and a 0.1 OD600 standardized suspension was then prepared by making dilutions in 
sterile cuvettes using broth as the diluent and the absorbance read blanked against a tube 
containing broth. The suspensions were then diluted to a final concentration of 1x105 cfu/ml 
with sufficient volume for the number of plates being used for the MIC determination 
(Standards, 2000) (Standard, 2002; Venugopal et al., 2010) .  
4.9 Minimum Inhibitory Concentration 
Minimum Inhibitory Concentration (MIC) was determined for the following organisms; 
Plague (Yersinia pestis), (Pohanka & Skladal, 2009; Revazishvili et al., 2008) Brucella, 
(Brucella melitensis, suis, or abortus),[64, 65] Anthrax (Bacillus anthracis), (Hicks et al., 2005; 
Koehler, 2009; Pohanka & Skladal, 2009) Glanders (Burkholderia mallei),(Harley, Dance, 
Drasar, & Tovey, 1998; Lehavi, Aizenstien, Katz, & Hourvitz, 2002; Manzeniuk et al., 1999) 
Melioidosis (Burkholderia pseudomallei), [71, 72] Staphylococcus aureus –MRSA [73, 74] 
and Tularemia (Francisella tularensis) (Pohanka & Skladal, 2009; Santic, Al-Khodor, & Abu 
Kwaik, 2009) Acinetobacter baumanii and a drug resistant clinical isolate strain of 
Acinetobacter baumanii (Walter Reed Army Institute of Research) using the following 
protocol.  All protocols used were approved by the appropriate review committee at the 
Walter Reed Army Institute of Research and are summarized below. Modifications of the 
NCCLS methods were employed for these analyses. [76, 77] A solution of Mueller Hinton 
Broth + IsoVitaleX (Bekton Dikinson, Inc.) was prepared containing1% Dimethylsulfoxide 
(DMSO Sigma Scientific) and referred to herein as HIBCD broth. Frozen antibiotic solutions 
were thawed and diluted to a final concentration of 500 µg/mL in HIBCD broth (Standards, 
2000) (Standard, 2002). Using a robotic sample processor (Precision XS, Biotek Instruments, 
Inc.), 15µL of HIBCD broth was transferred into all wells of a 384 well plate and the plate 
was then inoculated using 15µL of the organism suspension into all 384 wells using one 
organism per plate. The plates were incubated overnight and the optical density was read 
using the microplate reader (Spectromax Plus384) at a wavelength of 600nm and repeated at 
24 hour intervals until the control wells reached an optical density of 1.0OD. The MIC 
values correspond to the highest compound dilution with no measurable growth as 
determined from OD readings compared to both negative and control measurements 
(Standards, 2000) (Standard, 2002) (Venugopal et al., 2010).  
5. Conclusion 
Our laboratory has previously reported the development of a series of novel antimicrobial 
peptides (AMPs) that incorporate unnatural amino acids into their primary sequence to 
impart specific three-dimensional physicochemical properties onto the peptide (Hicks et al., 
2007,) (Bhonsle et al., 2007) (Venugopal et al., 2010) (Russell et al., 2010). Those AMPs 
exhibited low µM to nM in-vitro MIC antibacterial activity against several strains of Gram 
positive, Gram negative and mycobacterium. Many also exhibited very low hemolytic 
activity and low acute in vivo toxicity (125 mg/kg) in mice; these AMPs have also exhibited 
excellent metabolic stability in pooled human liver microsomes for up to 60 minutes 
(unpublished results).  (Hicks et al., 2007)(Venugopal et al., 2010). The first generation AMPs 
focused on the incorporation of three Tic-Oic dipeptide units separated by an amino acid 
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spacer (Spacer #1) and either a charged residue (Spacer 2) or a hydrophobic residue to 
control the conformational physicochemical properties of the AMP. Unnatural amino acids 
were selected for incorporation into the primary sequence of the AMP to provide peptide 
chemists with a “toolbox” of new functionality. This “toolbox” would allow for the 
development of novel peptides with specific physicochemical properties that will interact 
with cell membranes in novel ways thus providing entry to the synthesis of organism 
specific AMPs. The incorporation of unnatural amino acids into the peptide sequence of an 
AMP offers several advantages over an AMP consisting exclusively of naturally occurring 
amino acids. 1) Unnatural amino acids inherently exhibit greater metabolic stability. 
Therefore, incorporation of unnatural amino acids into the primary sequence generally 
results in an increase in metabolic stability compared to peptides consisting of only natural 
amino acids (Toke, 2005, Hancock and Lehrer, 1998). 2) The use of the conformationally 
restrained amino acids (Tic an Oic) reduces the local flexibility of the peptide backbone and 
thus reduces the total conformational space that may be sampled by the peptide during 
lipid binding. 
Here in the in vitro antibacterial activity and physical characterization of a new series of 
AMPs incorporating six Tic-Oic dipeptide units as well as four spacers, A, B, C and D on 
either side of the intervening hydrophobic and charged residues as well as a fifth spacer, E, 
which defines the distance between the polypeptide backbone and the positively charged 
side chain amine group is reported. This new series of AMPs is overall less active than the 
series containing only three Tic-Oic dipeptide units and two spacers. However, the new 
analogs exhibit far greater bacteria strain selectivity than the previously reported analogs. 
Induced calcein leakage studies, CD and ITC investigations indicate that the analogs 
containing six Tic-Oic dipeptide units and the additional spacers interact with POPC and 4:1 
POPC/POPG LUVs and SUVs somewhat differently than the previous analogs. These 
differences could account for the observed differences in bacteria strain selectivity. Induced 
calcein leakage studies, CD and ITC studies also indicate that the five spacers, A, B, C, D, 
and E contribute differently to organism selectivity and potency. For example Spacer D 
completely eliminates any activity, while Spacer A and E seem to play more important roles 
in defining organism selectivity and potency. 
What is clear from this study is that correct positioning of amino acids that influence the 
conformational and physicochemical properties that are favorable to interactions with a 
membrane with a specific chemical composition is critical to obtain organism selectivity and 
potency.  
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